Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Operating Expenses | 13,602 | 16,247 | 21,481 | 20,079 | 15,430 |
| Operating Income | -13,602 | -16,247 | -21,481 | -20,079 | -15,430 |
| Interest Expense | 336 | 12 | 0 | 0 | 0 |
| Other Income | 38 | 24 | 45 | 52 | -358 |
| Pre-tax Income | -13,900 | -16,235 | -21,436 | -20,027 | -15,788 |
| Net Income Continuous | -13,900 | -16,235 | -21,436 | -20,027 | -15,788 |
| Net Income | $-13,900 | $-16,235 | $-21,436 | $-20,027 | $-15,788 |
| EPS Basic Total Ops | -0.38 | -0.49 | -0.76 | -0.88 | -0.78 |
| EPS Basic Continuous Ops | -0.35 | -0.46 | -0.73 | -0.83 | -0.72 |
| EPS Diluted Total Ops | -0.38 | -0.49 | -0.76 | -0.88 | -0.78 |
| EPS Diluted Continuous Ops | -0.35 | -0.46 | -0.73 | -0.83 | -0.72 |
| EPS Diluted Before Non-Recurring Items | -0.38 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-13,602 | $-16,246 | $-21,474 | $-20,072 | $-15,420 |